EVEROLD LONG TERM FOLLOW-UP

Last updated: February 4, 2025
Sponsor: University Hospital, Brest
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT06504225
29BRC23.0069 - Everold FUP
  • Ages > 18
  • All Genders

Study Summary

Long Term Follow up of EVEROLD study

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Informed patients participating to the EVEROLD study

  • Patient having completed the EVEROLD M12 follow-up visit

  • Patient agreeing to participate in the observational study

Exclusion

Exclusion Criteria:

  • Opposition to the use his medical data

  • Patient under legal protection

Study Design

Total Participants: 260
Study Start date:
August 23, 2024
Estimated Completion Date:
August 01, 2025

Connect with a study center

  • Chu Amiens

    Amiens,
    France

    Active - Recruiting

  • CHU Bordeaux

    Bordeaux,
    France

    Active - Recruiting

  • Chu Brest

    Brest,
    France

    Active - Recruiting

  • CHU Lille

    Lille,
    France

    Active - Recruiting

  • CHU Limoges

    Limoges,
    France

    Active - Recruiting

  • CHU Nice

    Nice,
    France

    Active - Recruiting

  • CHU Nice Pasteur 2

    Nice,
    France

    Active - Recruiting

  • Hôpital Necker

    Paris,
    France

    Active - Recruiting

  • Chu Poitiers

    Poitiers,
    France

    Active - Recruiting

  • CHU Rennes

    Rennes,
    France

    Active - Recruiting

  • CHU Rouen

    Rouen,
    France

    Active - Recruiting

  • CHU Strasbourg

    Strasbourg,
    France

    Active - Recruiting

  • CHU Toulouse Rangueil

    Toulouse,
    France

    Active - Recruiting

  • CHU Tours

    Tours,
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.